The differential expression of somatostastin receptors in hepatocellular carcinoma HCCLM3 cell lines
ZHONG Zhao-hui,LI Shu,PENG Ji-run,ZHU Ji-ye,LENG Xi-sheng,ZHOU Mai,JIAO Gang-jun,GUO Yan-tong,HUANG Xun,WEI Yu-hua,YU Xin,钟朝辉,李澍,彭吉润,朱继业,冷希圣,周迈,焦岗军,郭晏同,黄迅,魏玉华,于鑫
DOI: https://doi.org/10.3760/j.issn:1007-631X.2006.04.020
2006-01-01
Abstract:Objective To investigate the mRNA and protein expression of somatostatin receptors in hepatocellular carcinoma HCCLM3 cell lines and to explore the mechanism by which somatostatin effects on hepatocellular carcinoma. Methods RT-PCR., immunocytochemistry and MTT were used to detect mRNA and protein expression of somatostatin receptors in hepatocellular carcinoma cells and evaluate the antiproliferative effect of somatostatin. Results The effect of somatostatin on the cellular proliferation was verified. Immunocytochemistry study revealed a mainly intracellular distribution of all SSTRs with unique patterns for each of them. mRNA expression of all 5 subtypes of somatostatin receptors was different, SSTR2 and SSTR1 mRNA expressions were significantly higher than SSTR3, SSTR4 and SSTR5 ( P < 0. 05 ). Conclusion All 5 subtypes of somatostatin receptors exist in hepatocellular carcinoma HCCLM3 cell lines. Cell proliferation is reduced by somatostatin and SSTR2,3,5 via a protein tyrosine phosphatase dependent mechanism.